Русский
Super-selective prostatic artery embolization as minimally invasive surgical treatment in patients with BPH
DOI: https://dx.doi.org/10.18565/urology.2021.5.100-104
V.K. Karpov, B.M. Sharapov, S.A. Kapranov , A.G. Zlatovratskiy, A.A. Kamalov
1) Department of Urology and Andrology (Head of the Department – academician, Ph.D., MD Kamalov A.A.), Faculty of Fundamental Medicine of Moscow State University by Lomonosov, Moscow, Russia; 2) Medical Scientific and Educational Center of Lomonosov Moscow State University (Director – academician, Ph.D., MD Kamalov A.A.), Moscow, Russia; 3) Pirogov Russian National Research Medical University (Rector – academician, Ph.D., MD Lukyanov S.A.), Moscow, Russia; 4GBUZ «GKB №31 DZM» (Chief – MD Ephremova N.M.), Moscow, Russia
Benign prostatic hyperplasia (BPH) is a widespread socially significant disease. Minimally invasive surgical treatments can reduce the surgical and anesthetic risk. One of the most effective methods of minimally invasive surgical treatment of BPH is superselective prostatic artery embolization (prostatic artery embolization; PAE). PAE is a method with proven effectiveness and has been included in the clinical recommendations of the Ministry of health of the Russian Federation for the treatment of BPH since 2019.
Keywords: BPH, minimally invasive surgical methods, PAE, embolization, superselective embolization of prostatic arteries
About the Autors
Corresponding author: Shaparov B.M. – Moscow Research and Education Center of the Lomonosov Moscow State University, urologist; Lomonosov Moscow State University, Faculty of Fundamental Medicine, Urology and Andrology Department, PhD student; e-mail: uroboris@mail.ru
